Tiziano Barbui^1*, Valerio De Stefano, MD^2*, Alessandra Carobbio, BSc^3*, Alessandra Iurlo, MD, PhD^4*, Alberto Alvarez-Larran, MD^5*, Alessandro Vannucchi, MD⁶, Francesca Palandri, MD, PhD^7*, Claire Harrison, DM, FRCPath⁸, Hassan Sibai, MBBS^9*, Martin Griesshammer, MD, PhD^10*, Massimiliano Bonifacio, MD^11,12*, Elena M Elli, MD^13*, Chiara Trotti, MD^14*, Steffen Koschmieder, MD¹⁵, Giuseppe Carli, MD^16*, Giulia Benevolo^17*, Jean-Christophe Ianotto, MD, PhD^18*, Swati Goel, MD^19*, Anna Falanga, MD²⁰, Silvia Betti, MD, PhD^21*, Daniele Cattaneo, MD^4*, Eduardo Arellano-Rodrigo, MD^22*, Lara Mannelli, MD^23*, Nicola Vianelli, MD^24*, Andrew Doyle, MBBS, BSc, FRPATH^25*, Vikas Gupta, MD, FRCP, FRCPath²⁶, Kai Wille, MD^27*, Douglas Tremblay, MD²⁸ and John Mascarenhas, MD²⁸

¹FROM Research Foundation ASST Papa Giovanni XXIII Bergamo, Bergamo, Italy
²Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy
³FROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, Italy
⁴Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
⁵Servicio de Hematologia, Hospital Clinic de Barcelona - GEMFIN, Barcelona, Spain
⁶CRIMM; Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy
⁷Institute of Hematology "L. & A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy
⁸Department of Clinical Haematology, Guys and St Thomas NHS Trust, London, United Kingdom
⁹Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
¹⁰University Clinic for Hematology, Oncology, Haemostaseology and Palliative Care, Johannes Wesling Medical Center, Minden, University of Bochum, Minden, Germany
¹¹Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
¹²Azienda Ospedaliera Universitaria Integrata, Policlinico G. Rossi, Verona, Italy
¹³Hematology, San Gerardo Hospital, MONZA, Italy
¹⁴Department of Molecular Medicine, University of Pavia, Pavia, Italy
¹⁵Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany
¹⁶Hematology Department, Ospedale San Bortolo, Vicenza, Italy
¹⁷AOU Città della Salute e della Scienza di Torino, Turin, Italy
¹⁸Clinical Hematology, Institut de Cancéro-Hématologie, Brest University Hospital, Brest, France
¹⁹Division of Hematology, Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
²⁰Immunohematology and Transfusion Medicine, ASST- Papa Giovanni XXIII, Bergamo, Italy
²¹Policlinico Universitario “A. Gemelli” IRCCS, Catholic University, Roma, Italy
²²Hospital Clinic de Barcelona- GEMFIN, Barcelona, Spain
²³CRIMM; Center Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence, Florence, Italy
²⁴Institute of Hematology "L. & A. Seragnoli", Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
²⁵Department of Haematology, Guy's & St Thomas' NHS Foundation Trust, London, ENG, United Kingdom
²⁶Princess Margaret Cancer Centre, Toronto, ON, Canada
²⁷Johannes Wesling Medical Center, University of Bochum, Bochum, Germany
²⁸Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

Srdan Verstovsek, MD, PhD¹, Valerio De Stefano, MD^2*, Florian H. Heidel, MD^3*, Mike Zuurman, PhD^4,5*, Michael Zaiac, MD^6*, Kenneth Bryan, PhD^7*, Brian Buckley, MSc^7*, Ashwini Mathur, PhD^7*, Mara Morelli, MD^5*, Erwan Bigan, PhD^8*, Michael Ruhl, PhD^8*, Christoph Meier, PhD^8*, Magali Beffy, PhD^8* and Jean-Jacques Kiladjian, MD, PhD⁹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Istituto di Ematologia, Università Cattolica, Fondazione Policlinico A. Gemelli IRCCS, Roma, Italy
³Universitätsklinikum Jena, Jena, Germany
⁴Novartis Pharma BV, Amsterdam, Gelderland, Netherlands
⁵Novartis Farma SpA, Origgio, VA, Italy
⁶Novartis Pharma AG, Basel, CH-NE, Switzerland
⁷Novartis Ireland Limited, Dublin, Ireland
⁸The Boston Consulting Group, Boston, Massachusetts
⁹Centre d’Investigations Cliniques, Hôpital Saint-Louis, Université de Paris, Paris, France

Stephen T. Oh, MD¹, Jason Gotlib, MD, MS², Sanjay Mohan, MD, MSCI³, Haris Ali, MD⁴, Ekatherine Asatiani, MD⁵, Francis Seguy^5*, Feng Zhou^6* and Srdan Verstovsek, MD, PhD⁷

¹Washington University School of Medicine, Saint Louis, MO
²Stanford Cancer Institute, Stanford, CA
³Vanderbilt University Medical Center, Nashville, TN
⁴City of Hope Medical Center, Duarte, CA
⁵Incyte Biosciences International Sàrl, Morges, Switzerland
⁶Incyte Corporation, Wilmington, DE
⁷Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Eliane Nguyen, MD^1,2, Natasha Szuber, MD^2,3,4, Michael Harnois^4,5*, Lambert Busque, MD^3,4,6, Luigina Mollica, MD, FRCPC, PhD^2,3,4, Sarit E Assouline, MD, MSc^4,7,8, Ines Chamakhi, MD, MD, FRCP(C)^3,4,9, Harold J. Olney, MD^3,4,10 and Shireen Sirhan, MD^4,8

¹Université de Montréal, Saint-Laurent, QC, Canada
²Department of Hematology, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada
³Université de Montréal, Montreal, QC, Canada
⁴Groupe Québécois de Recherche en LMC-NMP/Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Quebec Research Group (GQR LMC-NMP), Montreal, QC, Canada
⁵Hopital Maisonneuve Rosement, Montreal, QC, Canada
⁶Department of Hematology, Hôpital Maisonneuve Rosemont, Montreal, QC, Canada
⁷Segal Cancer Center, Lady Davis Institute, Jewish General Hospital, Montreal, Canada
⁸Division of Hematology, Sir Mortimer B. Davis-Jewish General Hospital, Department of Oncology, McGill University, Montreal, QC, Canada
⁹Department of Hematology, Hôpital Sacré-Coeur de Montréal, Montreal, QC, CAN
¹⁰Department of Hematology, Centre Hospitalier de l'Universite de Montreal, Montreal, QC, CAN

Jennifer A Mertz, PhD^1*, Patricia J Keller, PhD^1*, Rosana D Meyer, MD^1*, Oksana Zavidij, PhD^1*, Jike Cui, PhD^1*, Jean-Jacques Kiladjian, MD, PhD², Srdan Verstovsek, MD, PhD³, Vikas Gupta, MD, FRCP, FRCPath⁴, Moshe Talpaz, MD⁵, Claire Harrison, DM, FRCPath⁶, Adam J. Mead, MD, PhD⁷, Ruben Mesa, MD⁸, John Mascarenhas, MD⁹, Adrian Senderowicz, MD^1*, Gozde Colak, PhD^10*, James Shao, MS^1*, Katarina Luptakova, MD^1*, Jeffrey S Humphrey, MD¹, Jing Wang, PhD^1*, Patrick Trojer, PhD^1* and Mohamed E Salama, MD¹¹

¹Constellation Pharmaceuticals, Cambridge, MA
²Clinical Investigations Center, Saint-Louis hospital, Université de Paris, Paris, France
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
⁵Rogel Cancer Center, The University of Michigan, Ann Arbor, MI
⁶Guy's and St Thomas' Hospital, London, United Kingdom
⁷Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁸Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX
⁹Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY
¹⁰Constellation Pharmaceuticals, CAMBRIDGE, MA
¹¹Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Francesco Passamonti^1*, Kate Burbury, MBBS, FRACP, FRCPA, DPhil^2*, Tarec Christoffer El-Galaly³, Aaron T. Gerds, MD, MS⁴, Vikas Gupta, MD, FRCP, FRCPath⁵, Brian Higgins^6*, Ling-Yuh Huw, PhD^6*, Margherita Maffioli, MD^7*, Ruben Mesa, MD⁸, Jeanne M. Palmer, Md⁹, Alessandro Rambaldi, MD¹⁰, David M Ross, MBBS, PhD, FRACP, FRCPA^11*, Alessandro Vannucchi, MD¹², Abdulraheem Yacoub, MD¹³ and John Mascarenhas, MD¹⁴

¹Università Degli Studi Dell'Insubria, Varese, VA, Italy
²Peter MacCallum Cancer Centre, Melbourne, Australia
³F. Hoffmann-La Roche, Ltd., Basel, Switzerland
⁴Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁵Princess Margaret Cancer Centre, Toronto, ON, Canada
⁶Genentech, Inc., South San Francisco, CA
⁷ASST Sette Laghi, Ospedale di Circolo, Varese, ITA
⁸UT Health San Antonio Cancer Center, San Antonio, TX
⁹Mayo Clinic, Phoenix, AZ
¹⁰Department of Oncology and Hematology University of Milan and Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
¹¹Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
¹²Azienda Ospedaliero Universitaria Careggi, Firenze, Italy
¹³The University of Kansas Cancer Center, Leawood, KS
¹⁴Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

Charlotte K Brierley, MRCP, MD^1,2,3*, Alba Rodriguez-Meira, PhD^4*, Matthew Bashton, PhD^5*, Angela Hamblin, MD, PhD^3*, Rachel S Fletcher, PhD^6*, Sonia Fox^7*, Charlotte Gaskell, BSc, MSc^6*, Aimee Jackson, BSc, MSc^8*, Jennifer O'Sullivan, MD^1,3*, Lauren C Murphy^1,3*, Nikolaos Sousos, MD, MSc^1,3*, Amir Enshaei, PhD^9*, Claire Harrison, DM, FRCPath¹⁰, Mark W. Drummond, PhD, FRCPath^11,12*, Steve Knapper, BMBCh, MRCP, FRCPath, DM¹³, Bethan Psaila, MD^1,2,3 and Adam J. Mead, MD, PhD^2,3

¹MRC Weatherall Institute of Molecular Medicine, Oxford, United Kingdom
²Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
³NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
⁴MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
⁵The Hub for Biotechnology in the Built Environment, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom
⁶Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom
⁷Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Science, University of Birmingham, Birmingham, GBR
⁸Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, ENG, United Kingdom
⁹Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle-upon-Tyne, United Kingdom
¹⁰Department of Clinical Haematology, Guys and St Thomas NHS Trust, London, United Kingdom
¹¹Beatson Cancer Centre, Glasgow, United Kingdom
¹²Gartnavel General Hospital, Glasgow, United Kingdom
¹³Division of Cancer & Genetics, Cardiff University, Cardiff, United Kingdom

Soji Morishita, PhD^1*, Hajime Yasuda, MD, PhD^2*, Saya Yamawaki^3*, Hideya Kawaji, PhD^4*, Masayoshi Itoh, PhD^4*, Yoko Edahiro, MD, PhD^2*, Misa Imai, PhD^2*, Yasushi Kogo, PhD^4*, Satoshi Tsuneda, PhD^3*, Akimichi Ohsaka, MD, PhD^1*, Yoshihide Hayashizaki, MD, PhD^4*, Marito Araki, PhD^1* and Norio Komatsu, MD, PhD²

¹Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University Graduate School of Medicine, Tokyo, Japan
²Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan
³Department of Life Science and Medical Bioscience, Waseda University, Tokyo, Japan
⁴Preventive Medicine and Diagnosis Innovation Program, RIKEN, Saitama, Japan

Tapan M. Kadia, MD¹, Naveen Pemmaraju, MD¹, Musa Yilmaz, MD¹, Li Li, M.D.^2*, Mi-Ae Lyu, Ph.D.^2*, Meixian Huang, M.D., Ph.D.^2*, Ke Zeng, M.D.², Simrit Parmar, M.D., MSCI², Courtney D. DiNardo, MD, MSc³, Naval Daver, MD¹, Ghayas C. Issa, MD¹, Elias Jabbour, MD¹, Gautam Borthakur, MD⁴ and Srdan Verstovsek, MD, PhD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Jean-Jacques Kiladjian, MD, PhD¹, John Mascarenhas, MD², Rami Komrokji, MD³, Michele Cavo^4*, Bruno Martino, MD^5*, Dietger Niederwieser, MD, PhD⁶, Andreas Reiter, MD^7*, Bart L. Scott, MD⁸, Maria R. Baer, M.D.⁹, Ronald Hoffman, MD², Olatoyosi Odenike, MD¹⁰, Jacqueline Bussolari, PhD¹¹, Eugene Zhu, PhD^11*, Esther Rose, MD^11*, Laurie Sherman, BSN¹², Souria Dougherty, BS, MBA^12*, Faye Feller, MD¹², Libo Sun, PhD^12*, Ying Wan, PhD^12*, Aleksandra Rizo, MD, PhD¹², Fei Huang, PhD^12* and Alessandro Vannucchi, MD¹³

¹Hopital Saint-Louis, Paris, France
²Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
³H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁴Seragnoli Institute of Hematology, University of Bologna, Bologna, Italy
⁵Grande Ospedale Metropolitano-G.O.M. Bianchi-Melacrino-Morelli, Reggio Calabria, Italy
⁶University Hospital Leipzig, Leipzig, Germany
⁷University Hospital Mannheim, Mannheim, Germany
⁸Fred Hutchinson Cancer Research Center, Seattle, WA
⁹Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD
¹⁰University of Chicago, Chicago, IL
¹¹Janssen Research & Development, LLC, Raritan, NJ
¹²Geron Corporation, Parsippany, NJ
¹³AOU Careggi and University of Florence, Florence, Italy

John Mascarenhas, MD¹, Claire Harrison, DM, FRCPath², Katarina Luptakova, MD^3*, Jessica Christo, MA^3*, Jing Wang, PhD^3*, Jennifer A Mertz, PhD^3*, Gozde Colak, PhD^4*, James Shao, MS^3*, Suresh Bobba, MD^3*, Patrick Trojer, PhD^3*, Adrian Senderowicz, MD^3*, Jeffrey S Humphrey, MD³ and Srdan Verstovsek, MD, PhD⁵

¹Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY
²Guy's and St Thomas' Hospital, London, United Kingdom
³Constellation Pharmaceuticals, Cambridge, MA
⁴Constellation Pharmaceuticals, CAMBRIDGE, MA
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Jean Jacques Kiladjian, MD, PhD¹, Uwe Platzbecker, MD², Jiri Mayer, MD³, Árpád Illés, MD, PhD^4*, Witold Prejzner, MD, PhD^5*, Tomasz Wozny, MD, PhD^6*, Nikolay Tzvetkov, MD^7*, Alessandro Vannucchi, MD⁸, Ilya Kirgner, MD^9*, Zsolt Nagy, MD, PhD^10*, Sebastian Grosicki, MD, PhD¹¹, Åsa Rangert Derolf, MD PhD^12*, Mihaela Lazaroiu, MD¹³, Sung-Soo Yoon, MD, PhD¹⁴, Yeow Tee Goh, MBBS¹⁵, Nikolas Von Bubnoff^16,17,18*, Srdan Verstovsek, MD, PhD¹⁹, Barbara Jane Klencke, MD²⁰, Rafe Donahue, PhD^20* and Ruben Mesa, MD²¹

¹Université de Paris, Clinical Investigations Center, Saint-Louis hospital, APHP, Paris, France
²Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
³Department of Internal Medicine, Hematology and Oncology, Masaryk University Hospital, Brno, Czech Republic
⁴University of Debrecen, Faculty of Medicine, Department of Hematology, Debrecen, Hungary
⁵Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland
⁶Department of Hematology Szpital MSWiA w Poznaniu, Poznan, Poland
⁷UMHAT Dr. Georgi Stranski, EAD, Pleven, Clinic of Hematology, Pleven, Bulgaria
⁸CRIMM; Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy
⁹Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
¹⁰Semmelweis Egyetem I.sz, Belgyógyászati Klinika, Budapest, Hungary
¹¹Department of Hematology and Cancer Prevention, School of Public Health, Silesian Medical University, Katowice, Poland
¹²Department of Haematology, Karolinska University Hospital, Stockholm, Sweden
¹³Spitalul Judetean Brasov, BrașOv, ROU
¹⁴Seoul National University Hospital, Seoul, Korea, Republic of (South)
¹⁵Department of Hematology, Singapore General Hospital, Singapore, Singapore
¹⁶Department of Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
¹⁷Department of Hematology and Oncology, Medical Center, University of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany
¹⁸German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
¹⁹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²⁰Sierra Oncology Inc., Vancouver, BC, Canada
²¹UT Health San Antonio Cancer Center, San Antonio, TX

John Mascarenhas, MD¹, Alessandro Vannucchi, MD², Adam J. Mead, MD, PhD³, Regina Garcia-Delgado, MD^4*, Andrzej Pluta, MD^5*, Hope Qamoos, CNP^6*, Anne Uyei, MD^6*, Damaj Gandhi Laurent, MD, PhD^7* and Haifa K Al-Ali^8*

¹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²University of Florence, Florence, Italy
³MRC Weatherall Institute of Molecular Medicine, Oxford, United Kingdom
⁴Servicio de Hematologia, Hospital Virgen de la Victoria, Malaga, Spain
⁵Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im. Ks. B. Markiewicza, Brzozów, Poland
⁶Kartos Therapeutics, Inc., Redwood City, CA
⁷CHU Caen, Caen, France
⁸Department of Hematology and Medical Oncology, University Hospital of Halle, Halle, Germany

Jean-Jacques Kiladjian, MD, PhD¹, John Mascarenhas, MD², Rami S. Komrokji, MD³, Michele Cavo^4*, Bruno Martino, MD^5*, Dietger Niederwieser, MD, PhD⁶, Andreas Reiter, MD^7*, Bart L. Scott, MD⁸, Maria R. Baer, M.D.⁹, Ronald Hoffman, MD², Olatoyosi Odenike, MD¹⁰, Laurie Sherman, BSN¹¹, Souria Dougherty, BS, MBA^11*, Faye Feller, MD¹¹, Fei Huang, PhD^11*, Aleksandra Rizo, MD, PhD¹¹, Libo Sun, PhD^11*, Ying Wan, PhD^11* and Alessandro Vannucchi, MD¹²

¹Clinical Investigations Center, Saint-Louis hospital, Université de Paris, Paris, France
²Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
³H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴Seragnoli Institute of Hematology, University of Bologna, Bologna, Italy
⁵Grande Ospedale Metropolitano-G.O.M. Bianchi-Melacrino-Morelli, Reggio Calabria, Italy
⁶University Hospital Leipzig, Leipzig, Germany
⁷University Hospital Mannheim, Mannheim, Germany
⁸Fred Hutchinson Cancer Research Center, Seattle, WA
⁹Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD
¹⁰University of Chicago, Chicago, IL
¹¹Geron Corporation, Parsippany, NJ
¹²AOU Careggi and University of Florence, Florence, Italy

Srdan Verstovsek, MD, PhD¹, Shreekant Parasuraman, BPharm, PhD^2*, Jingbo Yu, MD, PhD², Anne Shah^3*, Shambhavi Kumar, MS^3*, Ann Xi, PharmD^3* and Claire Harrison, DM, FRCPath⁴

¹The University of Texas MD Anderson Cancer Center, Leukemia Department, Houston, TX
²Incyte Corporation, Wilmington, DE
³Avalere Health, Washington, DC
⁴Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London, United Kingdom

Ruben Mesa, MD^1,2, Heidi E. Kosiorek, MS^3*, Alessandra Carobbio, BSc^4*, Tiziano Barbui, MD^4* and Amylou C. Dueck, PhD⁵

¹Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX
²UT Health San Antonio Cancer Center, San Antonio, TX
³Mayo Clinic, Scottsdale, AZ
⁴FROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, Italy
⁵Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ

Samantha Ferrari, MD^1*, Chiara Pagani, MD^1*, Mariella D'Adda, MD^1*, Nicola Bianchetti, MD^1*, Annamaria Pelizzari, MD^1*, Doriana Gramegna, MD^1*, Chiara Bottelli, MD^1*, Luisa Lorenzi, MD^2*, Gabriella Vona^1*, Alessandra Tucci, MD^1* and Giuseppe Rossi, MD¹

¹Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
²Pathology, Dpt Molecular and Translational Medicine, University of Brescia, Brescia, Italy

Douglas Tremblay, MD¹, Naomi Alpert^2*, Emanuela Taioli, MD, PhD^2* and John Mascarenhas, MD¹

¹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY